Tech Company Financing Transactions

RedShift BioAnalytics Funding Round

RedShift BioAnalytics closed a $20 million Series E venture capital round on 10/19/2021. Investors included Illumina Ventures, Technology Venture Partners and Waters Corporation.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

131 Middlesex Turnpike
Burlington, MA 01803
USA

Phone

(781) 345-7300

Website

www.redshiftbio.com

Email Address

[email protected]

Overview

RedShiftBio is a provider of innovative analytical instrumentation for the research, development and manufacture of protein therapeutic drugs. The company has developed a powerful new analytical technique, Microfluidic Modulation Spectroscopy (MMS) that enables direct probing of the biophysical structure of proteins.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Julien Bradley

        

Chief Operating Officer

Chip Marshall

        

Chief Technical Officer

Eugene Ma

        

VP - Bus. Development

Jeffrey Zonderman

        

VP - Engineering

Richard Sharp

        

Browse more venture capital transactions:

Prev: 10/19/2021: Saildrone venture capital transaction
Next: 10/19/2021: Enpal venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary